Hamed Shahbazi
CEO

Healwell AI is a healthcare technology company that employs artificial intelligence and data science to enable early disease identification and risk assessment for patients. By developing algorithms that enhance clinical decision-making, Healwell AI aims to improve patient outcomes and reduce healthcare costs through timely diagnosis and personalized treatment pathways.
Raised to date
$38.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CEO
CEO
Healthcare providers often struggle with the early identification of complex or rare diseases due to the vast amount of patient data and the limitations of traditional diagnostic methods. This can lead to delayed diagnoses, increased healthcare costs, and poorer patient outcomes.
HEALWELL AI offers an AI-powered decision support system that analyzes patient data from EMRs to identify individuals at risk for over 100 different diseases, including both chronic and rare conditions. By applying advanced machine learning algorithms and clinical guidelines, the system risk-stratifies patients into high, medium, or low-risk categories, enabling healthcare providers to focus on those who need immediate attention. This early detection and risk assessment facilitate timely intervention, personalized treatment pathways, and improved patient outcomes while minimizing the risks of late or misdiagnosis. The platform integrates seamlessly into existing clinical workflows, providing evidence-based insights without increasing the burden on healthcare practices.
The primary target audience includes healthcare providers, physicians, and clinical researchers seeking to improve early disease detection, enhance patient care, and reduce healthcare costs through AI-driven insights.